Benzinga | Jan 10, 2022 09:22AM EST

Gilead Sciences Shares Move Higher; CEO Says Remdesivir Working Across All Known Variants Of COVID, Including Omicron; Says Co Working On Oral Form Of Remdesivir, Going Into Early Stage Trials Now

-CNBC Interview

(NASDAQ:GILD)